Skip to Main Content

Author Details

Dirce Maria Carraro
AC Camargo Cancer Center
1998
187
34
PMIDPaper TitleJournal TitlePublished Year
37995423Circulating tumor cells as a predictor and prognostic tool for metastatic clear cell renal carcinoma: An immunocytochemistry and genomic analysis.Pathol Res Pract2024
37855183Strong OLIG2 expression in supratentorial ependymoma, ZFTA fusion-positive: A potential diagnostic pitfall.Neuropathology2024
36703241Systemic immune mediators reflect tumour-infiltrating lymphocyte intensity and predict therapeutic response in triple-negative breast cancer.Immunology2023
37958811Characterization of Potential Melanoma Predisposition Genes in High-Risk Brazilian Patients.Int J Mol Sci2023
37485802Risk of metastasis in BRCA2 carriers diagnosed with triple-negative breast cancer.Cancer Med2023
37895483Multiple Primary Melanoma: A Five-Year Prospective Single-Center Follow-Up Study of Two MC1R R/R Genotype Carriers.Life (Basel)2023
38055384Are both distinct epithelial and stromal cells molecular analysis from phyllodes tumors versus fibroadenoma components affected in breast fibroepithelial progression?Acta Cir Bras2023
37569332CD47 Expression in Circulating Tumor Cells and Circulating Tumor Microemboli from Non-Small Cell Lung Cancer Patients Is a Poor Prognosis Factor.Int J Mol Sci2023
37536918Prevalence and clinical implications of germline pathogenic variants in cancer predisposing genes in young patients across sarcoma subtypes.J Med Genet2023
36947458Germline pathogenic variants in patients with early-onset neuroendocrine neoplasms.Endocr Relat Cancer2023
37181409Mortality by age, gene and gender in carriers of pathogenic mismatch repair gene variants receiving surveillance for early cancer diagnosis and treatment: a report from the prospective Lynch syndrome database.EClinicalMedicine2023
37104792Does the Addition of Mutations of CTNNB1 S45F to Clinical Factors Allow Prediction of Local Recurrence in Patients With a Desmoid Tumor? A Local Recurrence Risk Model.Clin Orthop Relat Res2023
36736685Amplicon-based NGS test for assessing MLH1 promoter methylation and its correlation with BRAF mutation in colorectal cancer patients.Exp Mol Pathol2023
34403526NTRK-rearranged mesenchymal tumour with epithelioid features: expanding the morphological spectrum of NTRK-fused neoplasms.Histopathology2022
35805051Triple-Negative Breast Cancer circRNAome Reveals Hsa_circ_0072309 as a Potential Risk Biomarker.Cancers (Basel)2022
35503891Actionable Mutation Profile of Sun-Protected Melanomas in South America.Am J Dermatopathol2022
36819813Li-Fraumeni-associated pancreatic neuroendocrine tumour and <i>XAF1</i> p.Glu134Ter risk modifier variant.Ecancermedicalscience2022
36551847High-Resolution Magic-Angle-Spinning NMR in Revealing Hepatoblastoma Hallmarks.Biomedicines2022
36099718Tight junction gene expression in salivary gland tumors.Pathol Res Pract2022
36064728A cross-sectional study of clinical, dermoscopic, histopathological, and molecular patterns of scalp melanoma in patients with or without androgenetic alopecia.Sci Rep2022
36201715Rhabdomyosarcomatous Transformation as a Mechanism of Resistance to Osimertinib and Savolitinib in EGFR-Mutant Lung Adenocarcinoma With <i>METamp</i> After Osimertinib First-Line Treatment.JCO Precis Oncol2022
36119527Characterization of genetic predisposition to molecular subtypes of breast cancer in Brazilian patients.Front Oncol2022
35320334Monitoring non-small cell lung cancer progression and treatment response through hyaluronic acid in sputum.Braz J Med Biol Res2022
35039532Value of the loss of heterozygosity to BRCA1 variant classification.NPJ Breast Cancer2022
35242225Dihydropyrimidine dehydrogenase (DPD) polymorphisms knocking on the door.Ecancermedicalscience2022
35085295Family-based whole-exome sequencing identifies rare variants potentially related to cutaneous melanoma predisposition in Brazilian melanoma-prone families.PLoS One2022
35303099Beyond Midline: Diffuse Hemispheric Glioma, H3 K27M-Mutant with Aggressive Behavior.J Neuropathol Exp Neurol2022
35200537Case Report of Small Cell Carcinoma of the Ovary, Hypercalcemic Type (Ovarian Rhabdoid Tumor) with <i>SMARCB1</i> Mutation: A Literature Review of a Rare and Aggressive Condition.Curr Oncol2022
32974876DNA Mismatch Repair-Deficient Colorectal Carcinoma: Referral Rate for Genetic Cancer Risk Assessment in a Brazilian Cancer Center.J Gastrointest Cancer2021
33852955DNA methylation as a key epigenetic player for hepatoblastoma characterization.Clin Res Hepatol Gastroenterol2021
33503190The mutational repertoire of uterine sarcomas and carcinosarcomas in a Brazilian cohort: A preliminary study.Clinics (Sao Paulo)2021
34956867Copy Number Alterations in Hepatoblastoma: Literature Review and a Brazilian Cohort Analysis Highlight New Biological Pathways.Front Oncol2021
34298749Genetic Landscape of Male Breast Cancer.Cancers (Basel)2021
33170334Multi-center real-world comparison of the fully automated Idyllaâ¿¢ microsatellite instability assay with routine molecular methods and immunohistochemistry on formalin-fixed paraffin-embedded tissue of colorectal cancer.Virchows Arch2021
33221980Impact of BRCA1/2 Mutations on the Efficacy of Secondary Cytoreductive Surgery.Ann Surg Oncol2021
33326660Whole-exome sequencing of non-BRCA1/BRCA2 mutation carrier cases at high-risk for hereditary breast/ovarian cancer.Hum Mutat2021
32432034Insights Into the Somatic Mutation Burden of Hepatoblastomas From Brazilian Patients.Front Oncol2020
31889631High Prevalence of EGFR Mutations in Lung Adenocarcinomas From Brazilian Patients Harboring the TP53 p.R337H Variant.Clin Lung Cancer2020
32039725Germline variants in DNA repair genes associated with hereditary breast and ovarian cancer syndrome: analysis of a 21 gene panel in the Brazilian population.BMC Med Genomics2020
33316873Deep Learning Predicts Underlying Features on Pathology Images with Therapeutic Relevance for Breast and Gastric Cancer.Cancers (Basel)2020
33256542Hepatoblastomas exhibit marked <i>NNMT</i> downregulation driven by promoter DNA hypermethylation.Tumour Biol2020
33134171Using Co-segregation and Loss of Heterozygosity Analysis to Define the Pathogenicity of Unclassified Variants in Hereditary Breast Cancer Patients.Front Oncol2020
32714871Mutational Portrait of Lung Adenocarcinoma in Brazilian Patients: Past, Present, and Future of Molecular Profiling in the Clinic.Front Oncol2020
32659967Clinical and Molecular Assessment of Patients with Lynch Syndrome and Sarcomas Underpinning the Association with <i>MSH2</i> Germline Pathogenic Variants.Cancers (Basel)2020
32592321Assessment of somatic mutations in urine and plasma of Wilms tumor patients.Cancer Med2020
32619713Three photobiomodulation protocols in the prevention/treatment of radiotherapy-induced oral mucositis.Photodiagnosis Photodyn Ther2020
32363481MLH1 intronic variants mapping toâ¿¿+â¿¿5 position of splice donor sites lead to deleterious effects on RNA splicing.Fam Cancer2020
32550004Sequencing technology status of <i>BRCA1/</i>2 testing in Latin American Countries.NPJ Genom Med2020
30303536From colorectal cancer pattern to the characterization of individuals at risk: Picture for genetic research in Latin America.Int J Cancer2019
31846472A transcriptome-based signature of pathological angiogenesis predicts breast cancer patient survival.PLoS Genet2019
  • 1 - 50 of 187

Recommended Authors

Charlotte K Y Ng
University of Bern
Career Start Year 2009
Number of shared co-authors 1
Xinmin Li
University of California los angeles
Career Start Year 2008
Number of shared co-authors 1
Salvatore Piscuoglio
University of Basel
Career Start Year 2008
Number of shared co-authors 2
Katia Nones
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 6
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 10
Ann-Marie Patch
QIMR Berghofer Medical Research Institute
Career Start Year 2005
Number of shared co-authors 9
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 3
Obi L Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 2
Peter Van Loo
The Francis Crick Institute
Career Start Year 2003
Number of shared co-authors 3
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 0
Olivier Harismendy
University of California
Career Start Year 2003
Number of shared co-authors 2
Volker Endris
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2001
Number of shared co-authors 1
Gad Getz
Broad Institute of the Massachusetts Institute of Technology and Harvard
Career Start Year 2000
Number of shared co-authors 3
Luciano G Martelotto
Monash University
Career Start Year 2000
Number of shared co-authors 1
Andrea Sboner
Institute for Computational Biomedicine
Career Start Year 2000
Number of shared co-authors 0
Colin C Pritchard
University of Washington, USA Brotman Baty Institute for Precision Medicine
Career Start Year 1999
Number of shared co-authors 4
Nuria Lopez-Bigas
Universitat Pompeu Fabra
Career Start Year 1999
Number of shared co-authors 3
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 3
Mar??a J Garc??a
Spanish National Cancer Research Centre (CNIO)
Career Start Year 1996
Number of shared co-authors 6
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Career Start Year 1995
Number of shared co-authors 1
Curtis Gumbs
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 1
Samuel Aparicio
University of British Columbia
Career Start Year 1993
Number of shared co-authors 2
Bauke Ylstra
Cancer Center Amsterdam, Vrije Universiteit Amsterdam
Career Start Year 1992
Number of shared co-authors 3
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year 1992
Number of shared co-authors 10
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 8
John W M Martens
Erasmus Medical Center (MC) Cancer Institute
Career Start Year 1989
Number of shared co-authors 8
Michael R Stratton
Wellcome Sanger Institute
Career Start Year 1987
Number of shared co-authors 12
David A Wheeler
Baylor College of Medicine
Career Start Year 1984
Number of shared co-authors 10
Irene L Andrulis
University of Toronto
Career Start Year 1977
Number of shared co-authors 12
Paolo Radice
Ospedale Circolo e Fondazione Macchi
Career Start Year 1969
Number of shared co-authors 16

Collaborators

Elisa Napolitano E Ferreira
A.C.Camargo Cancer Center
Co-authored papers 23
Anamaria A Camargo
Hospital Sirio-Libanes
Co-authored papers 15
Sandro J de Souza
Universidade Federal do Rio Grande do Norte
Co-authored papers 15
Maria Mitzi Brentani
Sao Paulo University
Co-authored papers 11
Andrew J G Simpson
University of Hull
Co-authored papers 10
Emmanuel Dias-Neto
A.C. Camargo Cancer Center
Co-authored papers 9
Maria Aparecida Azevedo Koike Folgueira
Center for Translational Oncology, Cancer Institute of the State of Sao Paulo - ICESP
Co-authored papers 9
Jorge Estefano Santana de Souza
Instituto Metropole Digital, Universidade Federal do Rio Grande do Norte
Co-authored papers 9
Maria Lucia Hirata Katayama
School of Medicine of Sao Paulo University
Co-authored papers 8
Wilson A Silva
Ribeirao Preto Medical School - University of Sao Paulo
Co-authored papers 8
Sabrina Daniela da Silva
Jewish General Hospital
Co-authored papers 7
Silvia Regina Caminada de Toledo
Pediatric Oncology Institute (IOP/GRAACC), Federal University of Sao Paulo
Co-authored papers 6
Pedro A F Galante
Hospital Sirio Libanes
Co-authored papers 6
Eduardo Carneiro de Lyra
Instituto Brasileiro de Controle do Cancer
Co-authored papers 5
Jo??o C Setubal
Chemistry Institute, Universidade de Sao Paulo - USP
Co-authored papers 4
Luiz F L Reis
Universidade Federal de Santa Maria
Co-authored papers 4
Diana N Nunes
A.C. Camargo Cancer Center
Co-authored papers 4
Rui Manuel Reis
Co-authored papers 4
Jo??o Carlos Sampaio G??es
Brazilian Institute of Cancer Control (IBCC)
Co-authored papers 4
Suely Kazue Nagahashi Marie
Co-authored papers 3
Ana Tereza Ribeiro de Vasconcelos
The National Laboratory for Scientific Computing (LNCC)
Co-authored papers 3
Marco A Zago
Center for Cell-Based Therapy (CTC)
Co-authored papers 3
Daniel G Pinheiro
Faculdade de Ciencias Agrarias e Veterinarias, Universidade Estadual Paulista (UNESP)
Co-authored papers 3
Webster K Cavenee
Ludwig Institute for Cancer Research, University of California San Diego
Co-authored papers 3
Marcio Luis Acencio
Norwegian University of Science and Technology
Co-authored papers 3
Anna C M Salim
Instituto Rene Rachou
Co-authored papers 3
Roger Chammas
Instituto do Cancer do Estado de Sao Paulo, Faculdade de Medicina de Sao Paulo
Co-authored papers 3
Raphael B Parmigiani
Sirio-Libanes Hospital
Co-authored papers 3
Otavia L Caballero
Ludwig Institute for Cancer Research Ltd.
Co-authored papers 2
Wadih Arap
Rutgers Cancer Institute of New Jersey
Co-authored papers 2
Release 1.2